Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
HKSE - Delayed Quote HKD

CanSino Biologics Inc. (6185.HK)

Compare
35.000
-0.500
(-1.41%)
At close: February 21 at 4:08:22 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
609,516
345,182
1,031,041
4,299,702
18,544
Cost of Revenue
521,897
1,221,201
1,217,648
1,297,769
13,804
Gross Profit
87,619
-876,019
-186,607
3,001,933
4,740
Operating Expense
957,378
1,202,887
1,261,962
1,201,354
445,063
Operating Income
-869,759
-2,078,906
-1,448,569
1,800,579
-440,323
Net Non Operating Interest Income Expense
19,409
35,714
24,098
58,957
31,581
Pretax Income
-924,745
-1,978,884
-1,184,001
1,936,787
-396,638
Tax Provision
-9,323
-11,451
-219,244
29,701
--
Net Income Common Stockholders
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Diluted NI Available to Com Stockholders
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Basic EPS
-3.51
-6.01
-3.68
7.74
-1.72
Diluted EPS
-3.51
-6.01
-3.68
7.74
-1.72
Basic Average Shares
246,783.500
246,766
247,022
247,450
230,917
Diluted Average Shares
247,449.899
246,766
247,022
247,450
230,917
Total Operating Income as Reported
-943,216
-2,035,182
-1,368,742
1,911,612
-400,859
Total Expenses
1,479,275
2,424,088
2,479,610
2,499,123
458,867
Net Income from Continuing & Discontinued Operation
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Normalized Income
-808,592.544
-1,525,326.091
-976,954.155
1,845,421.123
-434,786
Interest Income
87,178
100,057
65,928
79,651
31,721
Interest Expense
67,593
64,145
41,341
20,419
--
Net Interest Income
19,409
35,714
24,098
58,957
31,581
EBIT
-857,152
-1,914,739
-1,142,660
1,957,206
-396,638
EBITDA
-857,152
-1,645,686
-946,300
2,045,748
-364,821
Reconciled Cost of Revenue
521,897
1,221,201
1,217,648
1,297,769
13,804
Reconciled Depreciation
--
269,053
196,360
88,542
31,817
Net Income from Continuing Operation Net Minority Interest
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Total Unusual Items Excluding Goodwill
-58,675
42,842
82,868
70,043
38,148
Total Unusual Items
-58,675
42,842
82,868
70,043
38,148
Normalized EBITDA
-798,477
-1,688,528
-1,029,168
1,975,705
-402,969
Tax Rate for Calcs
0
0
0
0
--
Tax Effect of Unusual Items
-591.544
247.909
15,344.845
1,074.123
--
12/31/2020 - 3/28/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

688321.SS Shenzhen Chipscreen Biosciences Co., Ltd.
18.79
+3.98%
 
0013.HK HUTCHMED
25.450
+6.93%
 
600196.SS FOSUN PHARM
25.63
+0.20%
 
T14.SI Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
2.1500
+1.42%
 
2005.HK SSY Group Limited
3.320
+0.61%
 
2877.HK China Shineway Pharmaceutical Group Limited
8.440
+0.12%
 
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%
 
2096.HK Simcere Pharmaceutical Group Limited
7.900
+2.33%
 
4523.T Eisai Co., Ltd.
4,279.00
+0.87%
 
1558.HK HEC CJ PHARM
10.200
-1.92%